<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38909159</PMID><DateCompleted><Year>2025</Year><Month>02</Month><Day>05</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1530-0447</ISSN><JournalIssue CitedMedium="Internet"><Volume>97</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Pediatric research</Title><ISOAbbreviation>Pediatr Res</ISOAbbreviation></Journal><ArticleTitle>Cardiac evaluation of patients with juvenile dermatomyositis.</ArticleTitle><Pagination><StartPage>333</StartPage><EndPage>340</EndPage><MedlinePgn>333-340</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41390-024-03336-8</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The present study aims to evaluate possible cardiac involvement in juvenile dermatomyositis (JDM) patients by conventional methods and cardiac magnetic resonance imaging (MRI) along with a systematic review of the literature on cardiac features in JDM.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The study group consisted of JDM patients who underwent cardiac MRI. We conducted a systematic review of the published literature involving JDM patients with cardiac involvement.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In the present study, although baseline cardiologic evaluations including electrocardiography and echocardiography were within normal limits, we showed late gadolinium enhancement on cardiac MRI in 3 of 11 JDM patients. In the literature review, we identified 25 articles related to cardiac involvement in JDM. However, none of them, except one case report, included cardiac MRI of JDM patients.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Cardiac abnormalities have been reported among the less frequent findings in patients with JDM. Cardiovascular complications during the long-term disease course are a leading cause of morbidity and mortality in these patients. Early detection of cardiac involvement by cardiac MRI in patients with JDM and aggressive treatment of them may improve the clinical course of these patients.</AbstractText><AbstractText Label="IMPACT" NlmCategory="CONCLUSIONS">The myocardium in patients with JDM may be involved by inflammation. Myocardial involvement may be evaluated by using contrast-enhanced cardiac MRI. This is the first study evaluating cardiac involvement by cardiac MRI in JDM patients. MRI may show early cardiac involvement in patients whose baseline cardiologic evaluations are within normal limits. Early detection of cardiac involvement by cardiac MRI may improve the long-term prognosis of patients with JDM.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Akg&#xfc;n</LastName><ForeName>G&#xf6;kmen</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Pediatric Cardiology, City Hospital, Kocaeli, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S&#xf6;zeri</LastName><ForeName>Bet&#xfc;l</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Pediatric Rheumatology, University of Health Sciences, &#xdc;mraniye Research and Training Hospital, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ba&#x15f;ar</LastName><ForeName>Evi&#xe7; Zeynep</ForeName><Initials>EZ</Initials><AffiliationInfo><Affiliation>Department of Pediatric Cardiology, Kocaeli University, Faculty of Medicine, Kocaeli, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#x15e;ahin</LastName><ForeName>Nihal</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Pediatric Rheumatology, Kocaeli University, Faculty of Medicine, Kocaeli, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bayrak</LastName><ForeName>Yunus Emre</ForeName><Initials>YE</Initials><AffiliationInfo><Affiliation>Department of Pediatric Rheumatology, Kocaeli University, Faculty of Medicine, Kocaeli, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ulu</LastName><ForeName>Kadir</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Pediatric Rheumatology, University of Health Sciences, &#xdc;mraniye Research and Training Hospital, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xfc;ng&#xf6;r</LastName><ForeName>H&#xfc;seyin Salih</ForeName><Initials>HS</Initials><AffiliationInfo><Affiliation>Department of Pediatric Cardiology, Kocaeli University, Faculty of Medicine, Kocaeli, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Do&#x11f;an</LastName><ForeName>Mustafa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pediatric Cardiology, Kocaeli University, Faculty of Medicine, Kocaeli, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xd6;ner</LastName><ForeName>Taliha</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Pediatric Cardiology, University of Health Sciences, &#xdc;mraniye Research and Training Hospital, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karacan</LastName><ForeName>Mehmet</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pediatric Cardiology, University of Health Sciences, &#xdc;mraniye Research and Training Hospital, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Babao&#x11f;lu</LastName><ForeName>Kadir</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Pediatric Cardiology, Kocaeli University, Faculty of Medicine, Kocaeli, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>An&#x131;k</LastName><ForeName>Yonca</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Radiology, Kocaeli University, Faculty of Medicine, Kocaeli, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S&#xf6;nmez</LastName><ForeName>Hafize Emine</ForeName><Initials>HE</Initials><AffiliationInfo><Affiliation>Department of Pediatric Rheumatology, Kocaeli University, Faculty of Medicine, Kocaeli, Turkey. eminesonmez@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Pediatr Res</MedlineTA><NlmUniqueID>0100714</NlmUniqueID><ISSNLinking>0031-3998</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D003287">Contrast Media</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003287" MajorTopicYN="N">Contrast Media</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003882" MajorTopicYN="Y">Dermatomyositis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004452" MajorTopicYN="N">Echocardiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004562" MajorTopicYN="N">Electrocardiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006321" MajorTopicYN="Y">Heart</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009206" MajorTopicYN="N">Myocardium</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>Competing interests: The authors declare no competing interests</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>5</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>2</Month><Day>6</Day><Hour>0</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>23</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>22</Day><Hour>23</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>6</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38909159</ArticleId><ArticleId IdType="pmc">PMC11798830</ArticleId><ArticleId IdType="doi">10.1038/s41390-024-03336-8</ArticleId><ArticleId IdType="pii">10.1038/s41390-024-03336-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>McCann, L. J., Livermore, P., Wilkinson, M. G. L. &amp; Wedderburn, L. R. Juvenile dermatomyositis. Where are we now? Clin. Exp. Rheumatol.40, 394&#x2013;403 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35225221</ArticleId></ArticleIdList></Reference><Reference><Citation>Mondal, S., Barman, P. &amp; Vignesh, P. Cardiovascular abnormalities in juvenile dermatomyositis: a scoping review for the clinical rheumatologists. Front. Med.9, 827539 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9263083</ArticleId><ArticleId IdType="pubmed">35814777</ArticleId></ArticleIdList></Reference><Reference><Citation>Mavrogeni, S. et al. Myocarditis during acute inflammatory myopathies: evaluation using clinical criteria and cardiac magnetic resonance imaging. Int. J. Cardiol.164, e3&#x2013;e4 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23022085</ArticleId></ArticleIdList></Reference><Reference><Citation>Mavrogeni, S., Douskou, M. &amp; Manoussakis, M. N. Contrast-enhanced CMR imaging reveals myocardial involvement in idiopathic inflammatory myopathy without cardiac manifestations. JACC Cardiovasc. Imaging4, 1324&#x2013;1325 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">22172790</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohan, A. &amp; Peter, J. B. Polymyositis and dermatomyositis (first of two parts). N. Engl. J. Med.292, 344&#x2013;347 (1975).</Citation><ArticleIdList><ArticleId IdType="pubmed">1090839</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohan, A. &amp; Peter, J. B. Polymyositis and dermatomyositis (second of two parts). N. Engl. J. Med.292, 403&#x2013;407 (1975).</Citation><ArticleIdList><ArticleId IdType="pubmed">1089199</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundberg, I. E. et al. 2017 European League Against Rheumatism/American College of rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Arthritis Rheumatol.69, 2271&#x2013;2282 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5846474</ArticleId><ArticleId IdType="pubmed">29106061</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber, A. M. et al. Validation and clinical significance of the childhood myositis assessment scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies. Arthritis Rheum.50, 1595&#x2013;1603 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15146430</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerqueira, M. D. et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation105, 539&#x2013;542 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">11815441</ArticleId></ArticleIdList></Reference><Reference><Citation>Page, M. J. et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ372, 71 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira, R. M., Lerner, S., Maeda, W. T., Goldenstein-Schainberg, C. &amp; Cossermelli, W. Pericardial tamponade in juvenile dermatomyositis. Clin. Cardiol.15, 301&#x2013;303 (1992).</Citation><ArticleIdList><ArticleId IdType="pubmed">1563135</ArticleId></ArticleIdList></Reference><Reference><Citation>Jimenez, C., Rowe, P. C. &amp; Keene, D. Cardiac and central nervous system vasculitis in a child with dermatomyositis. J. Child Neurol.9, 297&#x2013;300 (1994).</Citation><ArticleIdList><ArticleId IdType="pubmed">7930410</ArticleId></ArticleIdList></Reference><Reference><Citation>Shehata, R. et al. Juvenile dermatomyositis: clinical profile and disease course in 25 patients. Clin. Exp. Rheumatol.17, 115&#x2013;118 (1999).</Citation><ArticleIdList><ArticleId IdType="pubmed">10084045</ArticleId></ArticleIdList></Reference><Reference><Citation>Hicks, J. E., Drinkard, B., Summers, R. M. &amp; Rider, L. G. Decreased aerobic capacity in children with juvenile dermatomyositis. Arthritis Rheum.47, 118&#x2013;123 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">11954004</ArticleId></ArticleIdList></Reference><Reference><Citation>Takken, T., Spermon, N., Helders, P. J., Prakken, A. B. &amp; Van Der Net, J. Aerobic exercise capacity in patients with juvenile dermatomyositis. J. Rheumatol.30, 1075&#x2013;1080 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12734909</ArticleId></ArticleIdList></Reference><Reference><Citation>Karaca, N. E., Aksu, G., Yeniay, B. S. &amp; Kutukculer, N. Juvenile dermatomyositis with a rare and remarkable complication: sinus bradycardia. Rheumatol. Int.27, 179&#x2013;182 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16944159</ArticleId></ArticleIdList></Reference><Reference><Citation>Sallum, A. M. et al. Risk factors associated with calcinosis of juvenile dermatomyositis. J. Pediatr.84, 68&#x2013;74 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18185899</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakurai, N., Nagai, K., Tsutsumi, H. &amp; Ichimiya, S. Anti-CADM-140 antibody-positive juvenile dermatomyositis with rapidly progressive interstitial lung disease and cardiac involvement. J. Rheumatol.38, 963&#x2013;964 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21532064</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz, T., Sanner, H., Husebye, T., Flato, B. &amp; Sjaastad, I. Cardiac dysfunction in juvenile dermatomyositis: a case-control study. Ann. Rheum. Dis.70, 766&#x2013;771 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21216816</ArticleId></ArticleIdList></Reference><Reference><Citation>Rider, L. G. et al. The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies. Medicine92, 223&#x2013;243 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3721421</ArticleId><ArticleId IdType="pubmed">23877355</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz, T., Sanner, H., Gjesdal, O., Flato, B. &amp; Sjaastad, I. In juvenile dermatomyositis, cardiac systolic dysfunction is present after long-term follow-up and is predicted by sustained early skin activity. Ann. Rheum. Dis.73, 1805&#x2013;1810 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">23881732</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz, T. et al. In active juvenile dermatomyositis, elevated eotaxin and MCP-1 and cholesterol levels in the upper normal range are associated with cardiac dysfunction. Rheumatology53, 2214&#x2013;2222 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24996906</ArticleId></ArticleIdList></Reference><Reference><Citation>Barth, Z. et al. In juvenile dermatomyositis, heart rate variability is reduced, and associated with both cardiac dysfunction and markers of inflammation: a cross-sectional study median 13.5 years after symptom onset. Rheumatology55, 535&#x2013;543 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26500284</ArticleId></ArticleIdList></Reference><Reference><Citation>Khera, R., Khare, S. &amp; Singh, S. K. Acute presentation of juvenile dermatomyositis with subclinical cardiac involvement: a rare case. J. Clin. Diagn. Res.10, SD01&#x2013;SD03 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5296542</ArticleId><ArticleId IdType="pubmed">28208969</ArticleId></ArticleIdList></Reference><Reference><Citation>Saini, I., Kalaivani, M. &amp; Kabra, S. K. Calcinosis in juvenile dermatomyositis: frequency, risk factors and outcome. Rheumatol. Int.36, 961&#x2013;965 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27007612</ArticleId></ArticleIdList></Reference><Reference><Citation>Berntsen, K. S. et al. Submaximal exercise capacity in juvenile dermatomyositis after longterm disease: the contribution of muscle, lung, and heart involvement. J. Rheumatol.44, 827&#x2013;834 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28365577</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantez, S., Gross, G. J., MacLusky, I. &amp; Feldman, B. M. Cardiac findings in children with juvenile Dermatomyositis at disease presentation. Pediatr. Rheumatol. Online J.15, 54 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5504613</ArticleId><ArticleId IdType="pubmed">28693511</ArticleId></ArticleIdList></Reference><Reference><Citation>Silverberg, J. I., Kwa, L., Kwa, M. C., Laumann, A. E. &amp; Ardalan, K. Cardiovascular and cerebrovascular comorbidities of juvenile dermatomyositis in US children: an analysis of the National Inpatient Sample. Rheumatology57, 694&#x2013;702 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29373707</ArticleId></ArticleIdList></Reference><Reference><Citation>Barth, Z. et al. Association between nailfold capillary density and pulmonary and cardiac involvement in medium to longstanding juvenile dermatomyositis. Arthritis Care Res.71, 492&#x2013;497 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">29953739</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh, R. et al. Juvenile dermatomyositis presenting as complete heart block in a 10-year-old girl. Paediatr. Int. Child Health40, 251&#x2013;254 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32427522</ArticleId></ArticleIdList></Reference><Reference><Citation>Diniz, M. F. R. et al. Echocardiographic study of juvenile dermatomyositis patients: new in sights from speckle-tracking-derived strain. Clin. Rheumatol.40, 1497&#x2013;1505 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">32989504</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart, J. A., Price, T., Moser, S., Mullikin, D. &amp; Bryan, A. Progressive, refractory macrophage activation syndrome as the initial presentation of anti-MDA5 antibody positive juvenile dermatomyositis: a case report and literature review. Pediatr. Rheumatol. Online J.20, 16 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8861992</ArticleId><ArticleId IdType="pubmed">35193600</ArticleId></ArticleIdList></Reference><Reference><Citation>Witczak, B. N. et al. Body composition in long-standing juvenile dermatomyositis: associations with disease activity, muscle strength and cardiometabolic measures. Rheumatology61, 2959&#x2013;2968 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">34718443</ArticleId></ArticleIdList></Reference><Reference><Citation>Witczak, B. N. et al. Associations between cardiac and pulmonary involvement in patients with juvenile dermatomyositis-a cross-sectional study. Rheumatol. Int.42, 1213&#x2013;1220 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9203373</ArticleId><ArticleId IdType="pubmed">34984516</ArticleId></ArticleIdList></Reference><Reference><Citation>Marstein, H. S. et al. Adipose tissue distribution is associated with cardio-metabolic alterations in adult patients with juvenile-onset dermatomyositis. Rheumatology62, SI196&#x2013;SI204 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9949708</ArticleId><ArticleId IdType="pubmed">35575380</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh, S. &amp; Bansal, A. Twelve years experience of juvenile dermatomyositis in North India. Rheumatol. Int.26, 510&#x2013;515 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16163542</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, L., Wang, G. C., Ma, L. &amp; Zu, N. Cardiac involvement in adult polymyositis or dermatomyositis: a systematic review. Clin. Cardiol.35, 686&#x2013;691 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6652370</ArticleId><ArticleId IdType="pubmed">22847365</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenbohm, A. et al. Early diagnosis of cardiac involvement in idiopathic inflammatory myopathy by cardiac magnetic resonance tomography. J. Neurol.262, 949&#x2013;956 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25673126</ArticleId></ArticleIdList></Reference><Reference><Citation>Diederichsen, L. P. et al. Cardiac abnormalities assessed by non-invasive techniques in patients with newly diagnosed idiopathic inflammatory myopathies. Clin. Exp. Rheumatol.33, 706&#x2013;714 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">26343166</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng, C. et al. Myocardial involvement characteristics by cardiac MR imaging in patients with polymyositis and dermatomyositis. Rheumatology61, 572&#x2013;580 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">33742670</ArticleId></ArticleIdList></Reference><Reference><Citation>Allanore, Y. et al. Effects of corticosteroids and immunosuppressors on idiopathic inflammatory myopathy related myocarditis evaluated by magnetic resonance imaging. Ann. Rheum. Dis.65, 249&#x2013;252 (2006).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1798005</ArticleId><ArticleId IdType="pubmed">16410529</ArticleId></ArticleIdList></Reference><Reference><Citation>Canter, C. E. &amp; Simpson, K. E. Diagnosis and treatment of myocarditis in children in the current era. Circulation129, 115&#x2013;128 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24396015</ArticleId></ArticleIdList></Reference><Reference><Citation>Satoh, H. et al. Distribution of late gadolinium enhancement in various types of cardiomyopathies: significance in differential diagnosis, clinical features and prognosis. World J. Cardiol.6, 585&#x2013;601 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4110607</ArticleId><ArticleId IdType="pubmed">25068019</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>